Contact this trialFirst, we need to learn more about you.
Small Molecule Inhibitor
Larotrectinib for Childhood Cancer
Recruiting1 awardPhase 1 & 2
Toronto, Ontario
This trial is testing the safety of a cancer drug called larotrectinib in children. The drug is designed to block the actions of genes in cancer cells. The trial will determine the dosage, how the drug is absorbed, and the response of different cancer types to the treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service